Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Cosmos Health Inc.

News headline image
Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Provides Balance Sheet Update: Highlights European Investment Bank Financing Discussions for up to €25M, Eliminates 38% of Warrant Overhang with No Dilution; Reaffirms Growth Trajectory; Notes No Known Business Reason for Recent Share Price
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Continues UK Retail Expansion for C-Scrub; Now Available at Superdrug, the UK’s Second-Largest Beauty and Health Retailer
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Announces Growing Momentum for C-Scrub in the United Kingdom; Now Available at Tesco, the UK’s Largest Retailer
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Announces Initiation of Analyst Coverage with $4.50 Valuation by Zacks Small-Cap Research
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
News headline image
Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy
From Cosmos Health Inc.
Via GlobeNewswire
Tickers COSM
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.